市場調查報告書
商品編碼
1291558
電子數據採集系統市場2023-2028年按交付模式、組件、開發階段、終端用戶和地區分類Electronic Data Capture Systems Market by Delivery Mode, Component, Development Phase, End User, and Region 2023-2028 |
全球電子數據採集(EDC)系統市場規模在2022年達到11.3億美元。展望未來,IMARC Group預計到2028年市場規模將達到23億美元,在2023-2028年期間表現出11.70%的成長率(CAGR)。臨床試驗的快速數位化、對雲端端基礎系統的不斷採用以及移動EDC的引入代表了推動市場發展的一些關鍵因素。
電子數據採集(EDC)系統是指旨在收集和管理電子格式的臨床試驗數據的軟體工具。它們採集各種各樣的數據,包括病人的人口統計、病史、不良事件、實驗室結果、臨床結果評估、電子知情同意書(eConsent)和研究地點資訊。 EDC系統被監管機構、臨床試驗申辦者、契約研究組織(CRO)、試驗參與者和數據管理者廣泛使用。它們有助於簡化數據收集,提高數據品質,盡量減少人為錯誤,保護敏感資訊,並減少數據丟失和重複的風險。 EDC系統還能提高臨床試驗的效率,提供即時監控能力,協助決策,並確保數據的準確性、可靠性和一致性。
全球範圍內臨床試驗的快速數位化是推動市場成長的主要因素之一。 EDC系統被廣泛用於自動化各種臨床試驗操作,如數據收集、存儲、監測和分析,這反過來又加快了進程,提供了透明度,防止了錯誤,並提高了整體效率。除此之外,由於糖尿病、高血壓、阿滋海默症、多發性硬化症和心血管疾病(CVDs)等慢性病的發病率不斷上升,對新的治療方法和療法的需求也在不斷成長,成為另一個成長的誘導因素。此外,擴大採用雲端端基礎系統,它具有成本效益,方便用戶使用,可擴展,高度安全,並提供即時訪問數據,正在為市場成長提供動力。此外,移動EDC的推出,利用智慧手機或平板電腦作為收集病人數據的方便和成本效益的方式,從而提高參與度,增加合規性,並減少錯誤的風險,有利於市場的成長。除此之外,機器學習(ML)和人工智慧(AI)的整合,以改善數據分析,實現更快的決策,並識別模式、趨勢和異常,正積極影響著市場的成長。此外,關於臨床試驗數據的安全性和完整性的嚴格政府法規的實施,促進了對先進的數據管理和報告系統的需求,如EDC,這有助於確保更符合當局的要求。其他因素,包括對個性化藥物需求的增加,廣泛的研究和開發(R&D)活動,以及對以病人為中心的臨床試驗的日益關注,預計將推動市場成長。
請注意,這只代表部分公司的名單,完整的名單已在報告中提供。
The global electronic data capture (EDC) systems market size reached US$ 1.13 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.3 Billion by 2028, exhibiting a growth rate (CAGR) of 11.70% during 2023-2028. The rapid digitalization of clinical trials, the rising adoption of the cloud-based system, and the introduction of mobile-EDC represent some of the key factors driving the market.
Electronic data capture (EDC) systems refer to software tools designed to collect and manage clinical trial data in electronic format. They capture a wide variety of data, including patient demographics, medical history, adverse events, laboratory results, clinical outcome assessments, electronic informed consent (eConsent), and study site information. EDC systems are widely used by regulatory agencies, clinical trial sponsors, contract research organizations (CROs), trial participants, and data managers. They help streamline data collection, improve data quality, minimize human errors, protect sensitive information, and reduce the risk of data loss and duplications. EDC systems also enhance the efficiency of the clinical trial, provide real-time monitoring capabilities, assist in decision-making, and ensure data accuracy, reliability, and consistency.
The rapid digitalization of clinical trials across the globe is one of the primary factors propelling the market growth. EDC systems are widely used to automate various clinical trial operations, such as data collection, storage, monitoring, and analysis, which, in turn, accelerate the process, provide transparency, prevent errors, and improve overall efficiency. In addition to this, the growing demand for new treatments and therapeutics due to the increasing prevalence of chronic diseases, such as diabetes, hypertension, Alzheimer's disease, multiple sclerosis, and cardiovascular diseases (CVDs), are acting as another growth-inducing factor. Furthermore, the rising adoption of the cloud-based system, which is cost-effective, user-friendly, scalable, highly secure, and offers real-time access to data, is providing an impetus to the market growth. Additionally, the introduction of mobile-EDC, which utilize smartphones or tablets as a convenient and cost-effective way to collect patients' data, thus improving engagement, increasing compliance, and reducing the risk of errors, is favoring the market growth. Apart from this, the integration of machine learning (ML) and artificial intelligence (AI) to improve data analysis, enable faster decision-making, and identify patterns, trends, and anomalies is positively influencing the market growth. Moreover, the implementation of stringent government regulations regarding the safety and integrity of clinical trial data is facilitating the demand for advanced data management and reporting systems, such as EDC, which aids in ensuring greater compliance with the authorities. Other factors, including increasing demand for personalized medicines, extensive research and development (R&D) activities, and the growing focus on patient-centric clinical trials, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global electronic data capture (EDC) systems market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on delivery mode, component, development phase, and end user.
The report has provided a detailed breakup and analysis of the electronic data capture (EDC) systems market based on the delivery mode. This includes on-premise and web & cloud-based. According to the report, web & cloud-based represented the largest segment.
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the component has also been provided in the report. This includes software and services. According to the report, services accounted for the largest market share.
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the development phase has also been provided in the report. This includes phase I, phase II, phase III, and phase IV. According to the report, phase III accounted for the largest market share.
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the end user has also been provided in the report. This includes hospitals/healthcare providers, CROs, pharmaceutical and biotechnology firms, medical device firms, and others. According to the report, CROs accounted for the largest market share.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for electronic data capture (EDC) systems. Some of the factors driving the North America electronic data capture (EDC) systems market included the rising prevalence of chronic diseases, increasing government initiatives, and rapid technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global electronic data capture (EDC) systems market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Anju Software Inc., Calyx, Clario, Datatrak Int, Medidata Solutions Inc., OpenClinica, LLC, Oracle Corporation, Veeva Systems, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.